- Global Pharma News & Resources

Press Releases - 2022-06-23

Date Title Company
23-Jun-2022 Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia Medacta Group SA
23-Jun-2022 New research reveals the critical actions needed to ensure COVID-19-driven surge in virtual health and care drives health access and equity Novartis Foundation
23-Jun-2022 Biological and Chemical Indicators Market to grow at CAGR of 7.2% through 2030 | FMI MARKITWIRED
23-Jun-2022 U.S. Animal Model Market is anticipated to increase at a high CAGR of 4.1 % (2022-2032) MARKITWIRED
23-Jun-2022 Weight Loss and Obesity Management Market to attain a valuation of US$ 4.99 Billion by 2028 MARKITWIRED
23-Jun-2022 Healthcare Regulatory Affairs Outsourcing Market size to US$ 2.54 Bn in 2028, at a CAGR 13.5% From (2022-2028) MARKITWIRED
23-Jun-2022 Orthopaedic Prosthetics Market Comprehensive Shares, Historical Trends And Forecast By 2030 MARKITWIRED
23-Jun-2022 Over-the-Counter Pain Medication Market is predicted to rise at a CAGR of 4.1% from 2022 to 2028 MARKITWIRED
23-Jun-2022 Bone Screw System Market is likely to grow at a CAGR of 6.4% through 2028, reaching US$ 1,963.9 Mn | FMI MARKITWIRED
23-Jun-2022 Companion Animals Drug Market is Expanding at a CAGR of 5% during the forecast period 2022-2027 MARKITWIRED
23-Jun-2022 PD-L1 Biomarker Testing Market is projected to reach a valuation of US$ 597.9 Million in 2022 MARKITWIRED
23-Jun-2022 Counterfeit Drug Detection Device Market Comprehensive Shares, Historical Trends And Forecast By 2029 MARKITWIRED
23-Jun-2022 Molybdenum 99 Market Competitive Growth Strategies Based on Type, Applications, End User and Region MARKITWIRED
23-Jun-2022 Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer Adrenomed AG
23-Jun-2022 Novotech Receives CRO Leadership Award for Exceeding Customer Expectations Novotech Health Holdings Pte Ltd
23-Jun-2022 Creative Peptides Unveils Product Portfolio of Standard Fmoc/Boc-PNA Monomers Creative Peptides
23-Jun-2022 APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052 APONTIS PHARMA AG
23-Jun-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Positive Independent Data Safety Monitoring Board Recommendation for Phase 2b Study of Varoglutamstat in AD (news with additional features) Vivoryon Therapeutics N.V.